Platelet count as a biomarker for monitoring treatment response and disease recurrence in recurrent epithelial ovarian cancer

Table 1 Relationship between clinicopathological parameters and different levels of plasma D-dimer, fibrinogen and serum CA125 in 104 patients with recurrent EOC

		Platelet count 1000cells/μl			Plasma Fibrinogen g/l			Plasma D-dimer mg/l			serum CA125 U/ml
Variable	n	≤300	> 300	P	2–4	> 4	P	≤0.3	> 0.3	P	≤35	> 35	P
Age, y				0.340			0.386			0.566			0.685
≤ 55	39	28	21		27	12		5	34		1	38
> 55	65	26	39		48	17		9	56		2	63
Stage				0.335			0.473			0.373			0.531
I or and II	23	11	12		16	7		4	19		1	22
III or and IV	81	33	48		59	22		10	71		2	79
Histological type				0.432			0.016			0.402			0.324
Serous	64	28	36		41	23		6	58		1	63
Non serous	40	16	24		34	6		8	32		2	38
Grade				0.021			0.273			0.410			0.549
Low	24	15	9		19	5		4	20		1	23
High	80	29	51		56	24		10	70		2	78
Postoperative residual disease				0.069			0.514			0.402			0.301
Microscopic	66	32	34		48	18		8	58		1	65
Macroscopic	38	12	26		27	11		6	32		2	36